Curexo Inc
Curexo Inc. engages in the development and sale of medical devices in Korea and internationally. Its products include ROBIN, a robot system that guides needle path induring CT-guided interventional procedure; Baidy, a medical device that assists labor by increasing intrauterine pressure which helps natural childbirth; artificial joint surgical robot; and Gait rehabilitation robot. The company als… Read more
Curexo Inc (060280) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.016x
Based on the latest financial reports, Curexo Inc (060280) has a cash flow conversion efficiency ratio of -0.016x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.49 Billion) by net assets (₩94.30 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Curexo Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Curexo Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Curexo Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Curexo Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Tianyong Engineering Co Ltd
SHG:603895
|
0.384x |
|
Richards Packaging Income Fund
PINK:RPKIF
|
0.055x |
|
Liaoning He Eye Hospital Group Co. LTD.
SHE:301103
|
N/A |
|
Zedcor Inc.
PINK:ZDCAF
|
0.133x |
|
SAMG Entertainment Co. Ltd.
KQ:419530
|
0.052x |
|
LPKF Laser & Electronics AG
PINK:LPKFF
|
0.065x |
|
PT Bangun Kosambi Sukses Tbk
JK:CBDK
|
0.019x |
|
SPECTRAL MEDICAL
F:SD4
|
N/A |
Annual Cash Flow Conversion Efficiency for Curexo Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Curexo Inc from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩93.38 Billion | ₩3.85 Billion | 0.041x | -18.50% |
| 2023-12-31 | ₩100.43 Billion | ₩5.08 Billion | 0.051x | +131.58% |
| 2022-12-31 | ₩81.68 Billion | ₩-13.08 Billion | -0.160x | +21.40% |
| 2021-12-31 | ₩42.90 Billion | ₩-8.74 Billion | -0.204x | -496.60% |
| 2020-12-31 | ₩44.79 Billion | ₩-1.53 Billion | -0.034x | +70.40% |
| 2019-12-31 | ₩43.98 Billion | ₩-5.08 Billion | -0.115x | +46.85% |
| 2018-12-31 | ₩70.03 Billion | ₩-15.20 Billion | -0.217x | -911.18% |
| 2017-12-31 | ₩70.69 Billion | ₩-1.52 Billion | -0.021x | +97.33% |
| 2016-12-31 | ₩73.08 Billion | ₩-58.79 Billion | -0.804x | -36.21% |
| 2015-12-31 | ₩33.51 Billion | ₩-19.79 Billion | -0.591x | +58.96% |
| 2014-12-31 | ₩13.94 Billion | ₩-20.06 Billion | -1.439x | -246.31% |
| 2013-12-31 | ₩35.09 Billion | ₩-14.58 Billion | -0.416x | -4.98% |
| 2012-12-31 | ₩49.48 Billion | ₩-19.59 Billion | -0.396x | -- |